Necessity and requirements of bridging studies and their present status in Japan

International Journal of Clinical Pharmacology and Therapeutics

Volumn 38, Issue 2, 2000, Pages 80-86

  Naito, C ^a  

^a TOKYO TEISHIN HOSPITAL   (Japan)

Author keywords

Bridging study; Ethnic factors; Foreign clinical data; Japanese bridging studies

Indexed keywords

CAPTOPRIL; DRUG; DRUG METABOLIZING ENZYME; HYDRALAZINE; ISONIAZID; MEPHENYTOIN; SALAZOSULFAPYRIDINE;

ACETYLATOR PHENOTYPE; ARTICLE; ASIAN; CAUCASIAN; CLINICAL STUDY; CULTURAL FACTOR; DOSE RESPONSE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; ETHNIC DIFFERENCE; ETHNOLOGY; GENETIC POLYMORPHISM; HUMAN; JAPAN; NEGRO; SOCIOECONOMICS;

EID: 0033960637     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP38080     Document Type: Article

References (12)

1. Eichelbaum M, Gross AS 1992 The genetic polymorphism of debrisoquine/sparteine metabolism clinical aspects. In: Kalow W (ed) Pharmacogenetics of Drug Metabolism. Pergamon Press, New York, pp 625-648
2. Evans DAP 1992 N-acetyltransferase. In: Kalow W (ed) Pharmacogenetics of Drug Metabolism. Pergamon Press, New York, pp 95-178
3. Homma M 1992 Requirements for the assessment of clinical safety regulatory perspectives. In: D'Arcy PF. Harron DWG (eds) Proceedings of The First International Conference on Harmonisation Brussels 1991. The Queen's University of Belfast, Northern Ireland, pp 390-399
4. Kaneko Y, Yamada K, Ikeda M, Omae T 1982 Anti-hypertensive effect of low-dose captopril in mild-to-moderate essential hypertension. Presented at the Ninth Scientific Meeting of the International Society of Hypertension, Mexico City, Mexico, February 21-24, Abstract 211
5. Naito C 1992 Some problems relating to dose response trials. In: D 'Arcy PF, Harron DWG (ed) Proceedings of The First International Conference on Harmonisation Brussels 1991. The Queen 's University of Belfast, Northern Ireland, pp 495-511
6. Naito C 1994a Ethnic factors in the acceptability of foreign data: Rapporteur's introduction. In: D'Arcy PF. Harron DWG (eds) Proceedings of The Second International Conference on Harmonisation Orlando 1993. The Queen's University of Belfast, Northern Ireland, pp 428-433
7. Naito C 1994b Ethnic effects on pharmacokinetic parameters. In: Walker S, Lumley C, McAuslane N (eds) The Relevance of Ethnic Factors in the Clinical Evaluation of Medicines. Kluwer Academic Publishers, London, pp 161-177
8. Naito C 1994c Evaluation methods for clinical trials of drugs in Japan which may affect ethnic differences. In: Walker S, Lumley C, McAuslane N (eds) The Relevance of Ethnic Factors in the Clinical Evaluation of Medicines. Kluwer Academic Publishers, London, pp 49-62
9. Sunahara S 1988 The practical side of the randomised clinical trial. In: Sunahara S (ed) Introduction to Study on Clinical Medicine. Methodology and Ethics. Igaku-Shoin, Tokyo, pp 106-134
10. Walker SR 1994 Survey on inter-ethnic differences in clinical responsiveness: Preliminary analyses of 21 compounds. In: D'Arcy PF, Harron DWG (eds) Proceedings of The Second International Conference on Harmonisation Orlando 1993. The Queen's University of Belfast, Northern Ireland, pp 443-452
11. Wilkinson GR, Guengerich P, Branch RA 1992 Genetic polymorphism of s-mephenytoin hydroxylation. In: Kalow W (ed) Pharmacogenetics of Drug Metabolism. Pergamon Press, New York, pp 657-685
12. Yasuhara H 1994 Which is more important in pharmacokinetics: Inter-ethnic or intra-ethnic variability? In: D 'Arcy PF, Harron DWG (eds) Proceedings of The Second International Conference on Harmonisation Orlando 1993. The Queen's University of Belfast, Northern Ireland, pp 436-443